⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria
globenewswire.com
REGN
SNY
Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)
globenewswire.com
REGN
SNY
Breakthrough T1D Celebrates Approval of Tzield for Use in Young Children to Delay the Onset of Insulin-Dependent Type 1 Diabetes
prnewswire.com
SNY
AI in Drug Discovery Market to Reach USD 160.49 Billion, Rising at a 23.22% CAGR by 2035
globenewswire.com
AMZN
JNJ
NVS
SNY
AZN
PFE
GSK
MRNA
BMY
LLY
MRK
ABBV
Paratus Appoints Alicia Secor as President and Chief Executive Officer; Expands Leadership Team to Support Next Phase of Growth
globenewswire.com
ZNTL
CRBU
AZN
PFE
TLRY
CATX
SYPR
SGBX
TMDX
LMT
TKO
TAK
SNY
EXAS
Press Release: Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children
globenewswire.com
SNY
Press Release: Sanofi provides update on the regulatory submission for Sarclisa subcutaneous in the US
globenewswire.com
SNY
Global Nasal Sprays Market to Reach USD 29.7 Billion by 2036, Driven by Rising Allergy Cases and Non-Oral Drug Demand
prnewswire.com
GSK
JNJ
NVS
AZN
PFE
MRK
SNY
THE SKIN OF COLOR SOCIETY (SOCS) SUCCESSFULLY PRESENTS LANDMARK SYMPOSIUM CHAMPIONING EVIDENCE-BASED DERMATOLOGY AND COLLABORATION
prnewswire.com
ABBV
JNJ
ARQT
BMY
LLY
INCY
SNY
REGN
PFE
UCB
BIIB
ORGN
TAK
ELMD
ISPE Announces 2026 Facility of the Year Awards (FOYA) Category Winners
prnewswire.com
AMGN
SNY
LLY
AZN
TAK